These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19127544)

  • 1. Diversity of participants in clinical trials in an academic medical center: the role of the 'Good Study Patient?'.
    Joseph G; Dohan D
    Cancer; 2009 Feb; 115(3):608-15. PubMed ID: 19127544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety-net hospital.
    Joseph G; Dohan D
    Contemp Clin Trials; 2009 Nov; 30(6):552-9. PubMed ID: 19580887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates.
    Grunfeld E; Zitzelsberger L; Coristine M; Aspelund F
    Cancer; 2002 Oct; 95(7):1577-83. PubMed ID: 12237928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial accrual among new cancer patients at a community-based cancer center.
    Go RS; Frisby KA; Lee JA; Mathiason MA; Meyer CM; Ostern JL; Walther SM; Schroeder JE; Meyer LA; Umberger KE
    Cancer; 2006 Jan; 106(2):426-33. PubMed ID: 16353206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and facilitators to participation of minorities in clinical trials.
    Schmotzer GL
    Ethn Dis; 2012; 22(2):226-30. PubMed ID: 22764647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.
    Costenbader KH; Brome D; Blanch D; Gall V; Karlson E; Liang MH
    Arthritis Rheum; 2007 Feb; 57(1):49-55. PubMed ID: 17266094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying motivations and barriers to patient participation in clinical trials.
    Jones JM; Nyhof-Young J; Moric J; Friedman A; Wells W; Catton P
    J Cancer Educ; 2006; 21(4):237-42. PubMed ID: 17542716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors that influence the recruitment of patients to Phase III studies in oncology: the perspective of the clinical research associate.
    Wright JR; Crooks D; Ellis PM; Mings D; Whelan TJ
    Cancer; 2002 Oct; 95(7):1584-91. PubMed ID: 12237929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials: the challenge of recruitment and retention of participants.
    Gul RB; Ali PA
    J Clin Nurs; 2010 Jan; 19(1-2):227-33. PubMed ID: 20500260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving enrollment in cancer clinical trials.
    Connolly NB; Schneider D; Hill AM
    Oncol Nurs Forum; 2004 May; 31(3):610-4. PubMed ID: 15146226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital.
    Ho J; Pond GR; Newman C; Maclean M; Chen EX; Oza AM; Siu LL
    BMC Cancer; 2006 Nov; 6():263. PubMed ID: 17092349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruiting participants to cancer prevention clinical trials: lessons from successful community oncology networks.
    McKinney MM; Weiner BJ; Wang V
    Oncol Nurs Forum; 2006 Sep; 33(5):951-9. PubMed ID: 16955123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The process of clinical trials: a model for successful clinical trial participation.
    Lengacher CA; Gonzalez LL; Giuliano R; Bennett MP; Cox CE; Reintgen DS
    Oncol Nurs Forum; 2001 Aug; 28(7):1115-20. PubMed ID: 11517845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nurse's primer on recruiting participants for clinical trials.
    Barrett R
    Oncol Nurs Forum; 2002 Aug; 29(7):1091-8. PubMed ID: 12183757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigator beliefs and reported success in recruiting minority participants.
    Williams IC; Corbie-Smith G
    Contemp Clin Trials; 2006 Dec; 27(6):580-6. PubMed ID: 16839822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cancer care and protocol characteristics associated with recruitment in breast cancer clinical trials.
    Lemieux J; Goodwin PJ; Pritchard KI; Gelmon KA; Bordeleau LJ; Duchesne T; Camden S; Speers CH
    J Clin Oncol; 2008 Sep; 26(27):4458-65. PubMed ID: 18802158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who refuses enrollment in cardiac clinical trials?
    Sen Biswas M; Newby LK; Bastian LA; Peterson ED; Sugarman J
    Clin Trials; 2007; 4(3):258-63. PubMed ID: 17715252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the multidisciplinary team in recruiting to cancer clinical trials.
    Maslin-Prothero S
    Eur J Cancer Care (Engl); 2006 May; 15(2):146-54. PubMed ID: 16643262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of consenter characteristics and experience on patient interest in clinical research.
    Rasco DW; Xie Y; Yan J; Sayne JR; Skinner CS; Dowell JE; Gerber DE
    Oncologist; 2009 May; 14(5):468-75. PubMed ID: 19401521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative recruitment experience in two large single-center randomized, controlled clinical trials.
    Galbreath AD; Smith B; Wood P; Forkner E; Peters JI
    Contemp Clin Trials; 2008 May; 29(3):335-42. PubMed ID: 18032118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.